CCL4 | | Target | Target | Eotaxin-2/CCL24 | | | | | | |
Ovarian Cancer | | Disease | Target | Kallikrein-8 | | | | | | |
CD68 | | Target | Target | AMAC-1 | | | | | | |
CD68 | | Target | Target | Eotaxin-2/CCL24 | | | | | | |
Skin Disease | | Disease | Target | Eotaxin-2/CCL24 | | | | | | |
Nausea | | Disease | Drug | Amitiza (Lubiprostone)- FDA | | | | | | |
Diarrhea | | Disease | Drug | Amitiza (Lubiprostone)- FDA | | | | | | |
Metastatic Breast Cancer | | Disease | Drug | Aralen (Chloroquine)- FDA | | | | | | |
Benign Prostatic Hyperplasia | | Disease | Target | Kallikrein-8 | | | | | | |
Androgen Receptor | | Target | Drug | Kaad-Cyclopamine | | | | | | |
Graft Versus Host Disease | | Disease | Target | AMAC-1 | | | | | | |
Chronic Pain | | Disease | Target | Mu-Type Opioid Receptor | | | | | | |
Osteoporosis | | Disease | Target | ALK Phos | | | | | | |
Dyspnea | | Disease | Drug | Amitiza (Lubiprostone)- FDA | | | | | | |
Headache | | Disease | Drug | Amitiza (Lubiprostone)- FDA | | | | | | |
Non Small Cell Lung Cancer | | Disease | Target | Kallikrein-8 | | | | | | |
Colon Cancer | | Disease | Target | Complement Decay-Accelerating Factor | | | | | | |
Osteoarthritis | | Disease | Target | ALK Phos | | | | | | |
Osteoarthritis | | Disease | Target | Kallikrein-8 | | | | | | |
CD4 | | Target | Target | Tegument Protein Vp16 | | | | | | |
Poisoning | | Disease | Target | ALK Phos | | | | | | |
CD4 | | Target | Target | Eotaxin-2/CCL24 | | | | | | |
Prostate Cancer | | Disease | Target | 464.1 | | | | | | |
Prostate Cancer | | Disease | Target | ALK Phos | | | | | | |
Prostate Cancer | | Disease | Target | Kallikrein-8 | | | | | | |
Renal Failure | | Disease | Target | 464.1 | | | | | | |
Renal Failure | | Disease | Target | ALK Phos | | | | | | |
Infection | | Disease | Target | Tegument Protein Vp16 | | | | | | |
Pneumonia | | Disease | Target | ALK Phos | | | | | | |
Anemia | | Disease | Target | ALK Phos | | | | | | |
Lung Cancer | | Disease | Drug | Kaad-Cyclopamine | | | | | | |
Lung Cancer | | Disease | Target | Kallikrein-8 | | | | | | |
Cancer | | Disease | Target | Kallikrein-8 | | | | | | |
CD4 | | Target | Target | Complement Decay-Accelerating Factor | | | | | | |
CD4 | | Target | Target | AMAC-1 | | | | | | |
Arthritis | | Disease | Target | Eotaxin-2/CCL24 | | | | | | |
Arthritis | | Disease | Target | Kallikrein-8 | | | | | | |
Shock | | Disease | Target | Tegument Protein Vp16 | | | | | | |
Tuberculosis | | Disease | Target | Eotaxin-2/CCL24 | | | | | | |
Carcinoma | | Disease | Target | Kallikrein-8 | | | | | | |
Depression | | Disease | Target | Mu-Type Opioid Receptor | | | | | | |
Diabetes | | Disease | Drug | Kaad-Cyclopamine | | | | | | |
Diabetes | | Disease | Target | 464.1 | | | | | | |
Diabetes | | Disease | Target | ALK Phos | | | | | | |
Cancer | | Disease | Drug | Aralen (Chloroquine)- FDA | | | | | | |
Infection | | Disease | Target | Eotaxin-2/CCL24 | | | | | | |
Carcinoma | | Disease | Target | 464.1 | | | | | | |
Cancer | | Disease | Target | 464.1 | | | | | | |
Cancer | | Disease | Target | ALK Phos | | | | | | |
Cancer | | Disease | Drug | Amitiza (Lubiprostone)- FDA | | | | | | |